ES8107185A1 - Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas - Google Patents

Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas

Info

Publication number
ES8107185A1
ES8107185A1 ES493230A ES493230A ES8107185A1 ES 8107185 A1 ES8107185 A1 ES 8107185A1 ES 493230 A ES493230 A ES 493230A ES 493230 A ES493230 A ES 493230A ES 8107185 A1 ES8107185 A1 ES 8107185A1
Authority
ES
Spain
Prior art keywords
compositions containing
methyl
preparation
pharmaceutical compositions
piperidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493230A
Other languages
English (en)
Other versions
ES493230A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8107185A1 publication Critical patent/ES8107185A1/es
Publication of ES493230A0 publication Critical patent/ES493230A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE PIPERIDINAS Y PIRROLIDINAS SUSTITUIDAS. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (I) EN FORMA DE RACEMATOS O SUS ISOMEROS OPTICAMENTE ACTIVOS CON UN AGENTE HIDROXIALCOHILANTE. EL PRODUCTO OBTENIDO (II) SE PUEDE TRANSFORMAR EN LA SAL DE ACIDO O LA SAL CUATERNARIA FARMACEUTICAMENTE ACEPTABLE. SE EMPLEA UN OXIDO DE ALCOHILENO COMO AGENTE HIDROXIALCOHILANTE. LA HIDROXIALCOHILACION SE EFECTUA EN PRESENCIA DE UN ACEPTOR DE ACIDO. *FORMULA*
ES493230A 1979-07-10 1980-07-09 Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas Granted ES493230A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7906000A SE431092B (sv) 1979-07-10 1979-07-10 Terapeutiskt aktiva, substituerade piperidinkarboxianilider

Publications (2)

Publication Number Publication Date
ES8107185A1 true ES8107185A1 (es) 1981-08-16
ES493230A0 ES493230A0 (es) 1981-08-16

Family

ID=20338488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493230A Granted ES493230A0 (es) 1979-07-10 1980-07-09 Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas

Country Status (19)

Country Link
US (1) US4302465A (es)
EP (1) EP0024382B1 (es)
JP (1) JPS5681561A (es)
AT (1) ATE6507T1 (es)
AU (1) AU538494B2 (es)
CA (1) CA1162924A (es)
CS (1) CS227011B2 (es)
DE (1) DE3066827D1 (es)
DK (1) DK290180A (es)
ES (1) ES493230A0 (es)
FI (1) FI802173A (es)
GR (1) GR69077B (es)
HU (1) HU180156B (es)
IL (1) IL60390A (es)
NO (1) NO802062L (es)
NZ (1) NZ194284A (es)
PL (1) PL125596B1 (es)
SE (1) SE431092B (es)
ZA (1) ZA803827B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443450A (en) * 1982-04-15 1984-04-17 Research Corporation Platelet aggregation inhibitory agents and intermediates therefor
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
US4859685A (en) * 1986-08-13 1989-08-22 Boc, Inc. Anesthetic composition and method of using the same
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US7910641B2 (en) 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
CA2636582A1 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film bandage for mucosal administration of actives
EP2063864A4 (en) 2006-09-20 2012-03-14 Monosol Rx Llc EDIBLE WATER-SOLUBLE FILM CONTAINING FLAVOR-REDUCING AGENT
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
EP2579844B1 (en) 2010-06-10 2016-02-24 Midatech Ltd. Nanoparticle film delivery systems
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
AU2016359706B2 (en) 2015-11-23 2022-07-28 Acasti Pharma U.S., Inc. Topical film-forming spray
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
MX2021007213A (es) 2018-12-19 2021-09-23 Grace therapeutics Inc Composicion terapeutica de lidocaina intranasal.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE191322C1 (es) 1964-01-01
SE164063C1 (es) 1958-07-22
SE191321C1 (es) 1964-01-01
US2792399A (en) * 1954-05-29 1957-05-14 Bofors Ab Anilides of heterocyclic compounds
US2799679A (en) * 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB889225A (es) * 1959-07-01
NL6803337A (es) 1967-03-20 1968-09-23
SE7607114L (sv) * 1976-06-22 1977-12-23 Bofors Ab Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
US4146628A (en) * 1977-08-04 1979-03-27 Edna Oppenheimer Antiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compounds
DE2742582A1 (de) * 1977-09-22 1979-04-05 Hoechst Ag Substituierte piperidinhydroxyamide, ihre herstellung und verwendung als lichtschutzmittel

Also Published As

Publication number Publication date
JPS6135178B2 (es) 1986-08-12
NZ194284A (en) 1983-06-14
SE431092B (sv) 1984-01-16
DE3066827D1 (en) 1984-04-12
DK290180A (da) 1981-01-11
US4302465B1 (es) 1984-01-24
ATE6507T1 (de) 1984-03-15
ZA803827B (en) 1981-06-24
JPS5681561A (en) 1981-07-03
HU180156B (en) 1983-02-28
GR69077B (es) 1982-04-26
AU538494B2 (en) 1984-08-16
NO802062L (no) 1981-01-12
US4302465A (en) 1981-11-24
PL225542A1 (es) 1981-12-23
CA1162924A (en) 1984-02-28
PL125596B1 (en) 1983-05-31
EP0024382A1 (en) 1981-03-04
EP0024382B1 (en) 1984-03-07
FI802173A (fi) 1981-01-11
SE7906000L (sv) 1981-01-20
IL60390A (en) 1984-10-31
CS227011B2 (en) 1984-04-16
AU6003280A (en) 1981-01-15
ES493230A0 (es) 1981-08-16

Similar Documents

Publication Publication Date Title
US4302465B1 (es)
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
ES484718A1 (es) Un procedimiento para la preparacion de benzopiranos.
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES8105715A1 (es) Procedimiento de preparar derivados isoquinolinicos
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES8104241A1 (es) Un procedimiento para la preparacion de compuestos derivadosde 1-((naftil substituido)etil)imidazol
ES476355A1 (es) Procedimiento para la obtencion de nuevos derivados de ari- laminoimidazolina
ES8603845A1 (es) Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acida y amobica cua- ternaria
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
ES481416A1 (es) Un procedimiento para la preparacion de un derivado monoami-da de acido tereftalico.
ES473909A1 (es) Procedimiento para la obtencion de derivados del acido ci- clohexil-4 naftaleno-acetico-1